These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9620117)

  • 1. Warfarin resistance in a patient with short bowel syndrome.
    Brophy DF; Ford SL; Crouch MA
    Pharmacotherapy; 1998; 18(3):646-9. PubMed ID: 9620117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous warfarin as an alternative for anticoagulation.
    Gellatly RM
    Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease.
    Akin F; Yaylali GF; Bastemir M; Yapar B
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin absorption after massive small bowel resection.
    Lutomski DM; LaFrance RJ; Bower RH; Fischer JE
    Am J Gastroenterol; 1985 Feb; 80(2):99-102. PubMed ID: 3970008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin, short bowel syndrome, and intravenous lipids.
    Lutomski DM
    Pharmacotherapy; 1998; 18(6):1375-6. PubMed ID: 9855342
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful anticoagulation and continuation of tramadol therapy in the setting of a tramadol-warfarin interaction.
    Dumo PA; Kielbasa LA
    Pharmacotherapy; 2006 Nov; 26(11):1654-7. PubMed ID: 17064212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful oral anticoagulant therapy in a patient with short bowel syndrome.
    Mitchell JF; Maas LC; Barger RC; Geizayd EA
    Am J Hosp Pharm; 1977 Feb; 34(2):171-2. PubMed ID: 842547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.
    Dickerson RN; Garmon WM; Kuhl DA; Minard G; Brown RO
    Pharmacotherapy; 2008 Mar; 28(3):308-13. PubMed ID: 18294110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible warfarin failure due to interaction with smokeless tobacco.
    Kuykendall JR; Houle MD; Rhodes RS
    Ann Pharmacother; 2004 Apr; 38(4):595-7. PubMed ID: 14766993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between warfarin and nafcillin: case report and review of the literature.
    Kim KY; Frey RJ; Epplen K; Foruhari F
    Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A subtherapeutic international normalized ratio despite increasing doses of warfarin: could this be malabsorption?
    Lara LF; Delgado LL; Frazee LA; Haupt KM; Rutecki GW
    Am J Med Sci; 2000 Sep; 320(3):214-8. PubMed ID: 11014378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin resistance: diagnosis and therapeutic alternatives.
    Hulse ML
    Pharmacotherapy; 1996; 16(6):1009-17. PubMed ID: 8947972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
    Parrish RH; Pazdur DE; O'donnell PJ
    Pharmacotherapy; 2006 Nov; 26(11):1650-3. PubMed ID: 17064211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulants and cyclosporin A.
    Turri D; Iannitto E; Caracciolo C; Mariani G
    Haematologica; 2000 Aug; 85(8):893-4. PubMed ID: 10942954
    [No Abstract]   [Full Text] [Related]  

  • 18. Unusual hypersensitivity to warfarin in a critically ill patient.
    Konishi H; Eguchi Y; Fujii M; Saotome T; Sasaki T; Takahashi K; Sudo M; Morii H; Minouchi T; Yamaji A
    J Clin Pharm Ther; 2004 Oct; 29(5):485-90. PubMed ID: 15482394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and ethnic differences in warfarin response.
    El Rouby S; Mestres CA; LaDuca FM; Zucker ML
    J Heart Valve Dis; 2004 Jan; 13(1):15-21. PubMed ID: 14765833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does heart failure exacerbation increase response to warfarin? A critical review of the literature.
    Self TH; Reaves AB; Oliphant CS; Sands C
    Curr Med Res Opin; 2006 Nov; 22(11):2089-94. PubMed ID: 17076968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.